Bit Capital Gmb H Bridge Bio Pharma, Inc. Transaction History
Bit Capital Gmb H
- $1.26 Trillion
- Q4 2024
A detailed history of Bit Capital Gmb H transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Bit Capital Gmb H holds 274,915 shares of BBIO stock, worth $8.56 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
274,915
Previous 222,421
23.6%
Holding current value
$8.56 Million
Previous $5.66 Billion
33.21%
% of portfolio
0.6%
Previous 0.53%
Shares
6 transactions
Others Institutions Holding BBIO
# of Institutions
299Shares Held
172MCall Options Held
10.4MPut Options Held
2.33M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$786 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$782 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$469 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$387 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$189 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.61B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...